4 European Projects Found
Searched on 125080 European Projects
FINISHED
Performance testing, calibration and implementation of a next generation system-of-systems Risk Governance Framework for nanomaterials (caLIBRAte)
Start date: May 1, 2016, End date: Oct 31, 2019,
The objective of the caLIBRAte project is to establish a state-of-the-art versatile Risk Governance framework for assessment and management of human and environmental risks of MN and MN-enabled products. The framework will be a web-based “system-of-systems” linking different models and methods for: 1) screening of apparent and perceived risks and trends in nanotechnology, 2) control banding, quali ...
Read Project
26
Partners Participants
FINISHED
Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD)
Start date: Oct 1, 2011, End date: Sep 30, 2015,
"In 2010 a widely marketed drug for the treatment of type 2 diabetes (T2DM) (rosiglitazone) was taken from the market as it was associated with an increased risk of myocardial infarction, a T2DM complication it was actually supposed to prevent. This example shows several things. First, the approval requirements do not guarantee a longer term positive benefit risk profile. Second, large scale postm ...
Read Project
19
Partners Participants
FINISHED
Pan European Grid Advanced Simulation and state Estimation (PEGASE)
Start date: Jul 1, 2008, End date: Jun 30, 2012,
...gh and Extra High Voltage transmission and sub-transmission networks in Europe (designated as ETN) and implemented by a Consortium composed of 20 Partners including TSOs, expert companies and leading research centre’s in power system analysis and applied mathematics. Its overall objectives are to define the most appropriate state estimation, optimization and simulation frameworks, their performanc ...
Read Project
25
Partners Participants
FINISHED
Safety Of non-Steroidal anti-inflammatory drugs (SOS)
Start date: Nov 1, 2008, End date: Apr 30, 2012,
"The Safety Of non-Steroidal anti-inflammatory drugs (SOS) proposal aims to assess the relative cardiovascular (CVD) and gastrointestinal (GI) safety of non-steroidal anti-inflammatory drugs (NSAIDs). The NSAIDs are divided in traditional NSAIDs (tNSAIDs) and the newer COX-II inhibitors(coxibs). The aim will be fulfilled by a two-phase approach comprising systematic reviews and synthesis of CVD an ...
Read Project
